Overview
Faculty
Upcoming Events
View Archive

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Onco-Nurse Academy™ (Virtual Grand Rounds Edition): Navigating Cholangiocarcinoma Management with Targeted and Immuno-Therapies

Onco-Nurse Academy™ (Virtual Grand Rounds Edition): Navigating Cholangiocarcinoma Management with Targeted and Immuno-Therapies


Onco-Nurse Academy™ (Virtual Grand Rounds Edition): Navigating Cholangiocarcinoma Management with Targeted and Immuno-Therapies

In order to request this CME/CE activity for your center, please contact Samantha Zelasko at SZelasko@gotoper.com

Date: July 12th- 12:00pm-1:00pm EST

Overview

The management of cholangiocarcinoma has undergone a significant shift in recent years, due in large part to the refinement of systemic therapy. The use of targeted therapies and immunological therapies continues to evolve, as novel treatment options continue to be developed. With this evolution of the treatment landscape, continuing education for nursing professionals is warranted to achieve optimized patient outcomes.

This live webcast is specifically designed to educate and empower nursing professionals who provide health care to patients with cholangiocarcinoma. It will feature expert faculty sharing data and clinical insights on the recent trial data supporting emerging targeted and immunologic therapies in the standard of care. The webcast will feature 3 modules, each focusing on a different aspect of management and supported by clinical cases to provide context for treatment selection, barriers to treatment, and management of adverse events.

Benefits of Attending

  • Engage thought leaders in the management of cholangiocarcinoma across different treatment settings
  • Bring your burning clinical questions to ask an esteemed group of faculty
  • Hear discussion of challenging cases in cholangiocarcinoma
  • Refresh your knowledge of new and upcoming treatment options for cholangiocarcinoma

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Incyte Corporation.

Target Audience

This educational program is directed toward nurses and other healthcare professionals with an interest in the treatment of gastrointestinal cancers.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate the rationale for emerging targeted and immunotherapeutic strategies and their application in cholangiocarcinoma
  • Assess the efficacy and safety profiles of emerging agents and combinations evaluated in patients with cholangiocarcinoma
  • Implement multidisciplinary strategies to identify and mitigate toxicities associated with current and emerging therapies for cholangiocarcinoma
  • Apply knowledge of treatment-related toxicities and testing strategies to inform effective counseling and care coordination for patients with cholangiocarcinoma

Program Chair

Gabriel Schwatrz, MSN, FNP-BC, AOCNP
Gabriel Schwartz, MSN, FNP-BC, AOCNP
Nurse Practitioner
Department of GI Medical Oncology
Assistant Clinical Professor
Department of Family Healthcare Nursing
University of California, San Francisco Medical Center
San Francisco, California

Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By